Internal Medicine | Page 219 of 487 | Links Medicus Content Curation & Alerts in Medicine

ERC and ESICM Guidelines: Post-resuscitation Care

26 Mar, 2021 | 08:41h | UTC

European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care – Intensive Care Medicine

Commentary on Twitter

Post #resuscitation @ERC_resus @ESICM guidelines #resus21
🫀diagnosis & reperfusion
🫀post CA syndrome
🫀hemodynamics
🫁oxygenation/ventilation
🧠general #ICU approach
🧠seizures control
🌡️TTM
🧠prognosis & outcome
💪#ICUrehab
🫁organ donation
🏥CA centershttps://t.co/BrPJtKw8vo pic.twitter.com/xS0FKFSK6F

— Intensive Care Medicine (@yourICM) March 25, 2021

M-A: Fracture risk is lower in patients anticoagulated with NOACs compared to patients treated with warfarin

26 Mar, 2021 | 08:26h | UTC

Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta‐Analysis – Journal of the American Heart Association

Commentary: NOACs associated with a 16% lower risk of bone fractures than warfarin – Cardiovascular Business

State of the Art Review | Management of colonic diverticulitis

25 Mar, 2021 | 08:14h | UTC

Management of colonic diverticulitis – The BMJ

Commentary on Twitter

NEW 🔥💥State of the Art Clinical Review @bmj_latest
Management of colonic diverticulitis #IDTwitter https://t.co/aUOGYZ8I4n pic.twitter.com/vYjzQ50LY1

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) March 24, 2021

RCT: Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc

25 Mar, 2021 | 08:12h | UTC

Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluation – The Lancet Rheumatology

Commentary on Twitter

NEW RESEARCH—Surgical microdiscectomy and
transforaminal epidural steroid injection are similarly effective at reducing #pain and disability from #sciatica secondary to herniated lumbar disc https://t.co/xXOr1aOX8K #LancetRheumatology #OpenAccess pic.twitter.com/2CHh1YD2gm

— The Lancet Rheumatology (@TheLancetRheum) March 19, 2021

Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine

26 Mar, 2021 | 09:01h | UTC

Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine – STAT

News release: AZD1222 US Phase III primary analysis confirms safety and efficacy – AstraZeneca

Practice Pointer: Remote management of Covid-19 using home pulse oximetry and virtual ward support

26 Mar, 2021 | 09:05h | UTC

Remote management of covid-19 using home pulse oximetry and virtual ward support – The BMJ

Commentary on Twitter

https://twitter.com/trishgreenhalgh/status/1375110854094520322

Another study shows increased transmissibility of SARS-CoV-2 lineage B.1.1.7 with a 50% to 100% higher reproduction number

26 Mar, 2021 | 08:57h | UTC

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England – Nature

Related: Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7 (study and commentary)

Commentary on Twitter

Just published @nature: Transmissibility of the B.1.1.7 (UK) variant https://t.co/dsMge8bB83 "A substantial transmission advantage with a 50 to 100% higher reproduction number"
Secondary attack rates were 30-40% higher than ancestral strain (non-VOC); no age gradient by modeling pic.twitter.com/870A3PojyF

— Eric Topol (@EricTopol) March 25, 2021

Covid: The London bus trip that saved maybe a million lives (about the creation of the RECOVERY Trial)

26 Mar, 2021 | 08:53h | UTC

Covid: The London bus trip that saved maybe a million lives – BBC

Commentary on Twitter

Very cool story by @JamesTGallagher about a convo on a London bus that led to the creation of the RECOVERY trial, which has been a shining (& too rare) example of how to do critical research in a pandemic. Bravo @PeterHorby & @MartinLandray h/t @hildabast https://t.co/BRSJLSFXdc

— Helen Branswell 🇨🇦 (@HelenBranswell) March 25, 2021

[Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior

25 Mar, 2021 | 08:10h | UTC

Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior – Médecins Sans Frontières

Commentary on Twitter

Promising news improving treatment #MDR #TB https://t.co/Lxjb7LBofy Translating findings to available drugs & diagnostics back it up will be key pic.twitter.com/YGp8d9ixww

— Michael Marks (@dr_michaelmarks) March 24, 2021

Modeling study suggest patients should receive COVID-19 vaccine before surgery to reduce the risk of death

26 Mar, 2021 | 08:43h | UTC

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study – University of Birmingham

Original study: SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study – British Journal of Surgery

USPSTF Statement: Current evidence is insufficient to recommend screening for hearing loss in older adults

24 Mar, 2021 | 08:12h | UTC

Screening for Hearing Loss in Older Adults – U.S. Preventive Services Task Force

Editorial: Screening for Hearing Loss in Older Adults: Insufficient Evidence Does Not Mean Insufficient Benefit – JAMA AND United States Preventive Services Task Force Recommendation for Hearing-Loss Screening Among Older Adults: An Opportunity in Insufficient Evidence – AMA Otolaryngology-Head & Neck Surgery AND USPSTF Recommendations for Hearing Loss Screening in Asymptomatic Older Adults—A Case of Missing Evidence and Missing Treatment Options – JAMA Network Open

Evidence Report: Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author interview: USPSTF Recommendation: Screening for Hearing Loss in Older Adults – JAMA

JAMA Patient Page: Screening for Hearing Loss in Older Adults

Review: Use of urine electrolytes and urine osmolality in the clinical diagnosis of fluid, electrolytes, and acid-base disorders

25 Mar, 2021 | 08:06h | UTC

Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders – KI Reports

Commentary on Twitter

Do people use Urine K/crt ratio? for K disorders? What about FeK? TTKG is out! @askrenal –this flow chart makes sense to me https://t.co/8o8a7VYTMQ pic.twitter.com/UVZiFPo4vK

— Kenar Jhaveri (@kdjhaveri) February 20, 2021

RCT: Aspirin NOT noninferior to vitamin K antagonists in the treatment of cervical artery dissection

24 Mar, 2021 | 08:09h | UTC

Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial – The Lancet Neurology (link to abstract – $ for full-text)

WHO Campaign | World Tuberculosis Day 2021: The Clock Is Ticking

24 Mar, 2021 | 08:16h | UTC

World Tuberculosis Day 2021: The Clock Is Ticking – World Health Organization

Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

25 Mar, 2021 | 08:34h | UTC

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications – New England Journal of Medicine

Systematic review: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

25 Mar, 2021 | 08:38h | UTC

Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library

Commentaries: Updated Cochrane review assesses how accurate rapid tests are for detecting COVID-19 – Wiley AND Expert reaction to updated Cochrane review of studies on accuracy of rapid tests (including lateral flow and molecular tests) to detect SARS-CoV-2 – Science Media Centre

NICE publishes single guideline for managing COVID-19

24 Mar, 2021 | 08:42h | UTC

NICE publishes single guideline for managing COVID-19 – National Institute for Health and Care Excellence

News release: COVID-19 rapid guideline: managing COVID-19 – National Institute for Health and Care Excellence

Commentary on Twitter

Today NICE has published a single guideline for managing COVID-19, which brings together content from previous rapid COVID-19 guidance and evidence summaries. Read more: https://t.co/3O5yzpHK9e pic.twitter.com/DyD7lcLX8v

— NICE (@NICEComms) March 23, 2021

RCT: Effect of continued weekly subcutaneous Semaglutide vs. placebo on weight loss maintenance in adults with overweight or obesity

24 Mar, 2021 | 08:05h | UTC

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial – JAMA (free for a limited period)

Commentaries: Continuing Semaglutide Leads to Further Weight Loss – NEJM Journal Watch AND STEP 4: Long-term treatment needed for full semaglutide benefit – MedwireNews

Podcast: Semaglutide for Weight Loss – JAMA

Commentary on Twitter

In this RCT, weekly subcutaneous subcutaneous semaglutide resulted in increased weight loss over 48 weeks vs placebo in adults with #overweight or #obesity https://t.co/Ze6zHCG1Fd

— JAMA (@JAMA_current) March 23, 2021